Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) Has Another Chance To Impress You
Currently, there are 257.00M common shares owned by the public and among those 256.33M shares have been available to trade. The company’s stock has a 5-day price change of -10.62% and -6.69% over the past three months. VRTX shares are trading 11.75% year to date (YTD), with the 12-month market performance up to 12.46% higher. […]
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) – Suitable For Long Term Buy?
Currently, there are 257.70M common shares owned by the public and among those 256.81M shares have been available to trade. Insiders at the company have transacted a total of 198 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, […]
